Clinical Edge Journal Scan

Vascular Inflammation is Increased in Patients with PsA


 

Key clinical point: Patients with psoriatic arthritis (PsA) had significantly higher levels of aortic vascular inflammation as measured by 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) scanning than control individuals without PsA who had melanoma.

Major finding: Vascular inflammation of the whole aorta was significantly increased in patients with PsA vs control individuals (mean target-to-background ratio 1.63 vs 1.49; P < .001), with the association remaining significant even after adjusting for gender, age, body mass index, mean arterial pressure, and aortic calcification (P = .002). Patients with PsA vs control individuals also had a higher extent of inflammation in other aortic segments.

Study details: Findings are from cross-sectional study that included 75 patients with active PsA and 40 control individuals without PsA who were diagnosed with melanoma without distant metastases, all of whom underwent FDG PET/CT scans.

Disclosures: This study was funded by Health Holland and Pfizer. Four authors declared serving as consultants or advisors for, receiving research grants from, or having other ties with various sources, including Pfizer.

Source: Kleinrensink NJ, Spierings J, Vonkeman HE, et al. Increased vascular inflammation on PET/CT in psoriatic arthritis patients in comparison with controls. RMD open. 2024;10:e003547 (Jan 30). doi: 10.1136/rmdopen-2023-003547 Source

Recommended Reading

Age at natural menopause and reproductive lifespan tied to PsA risk
MDedge Rheumatology
Acidogenic diet may be negative in patients with PsA
MDedge Rheumatology
A Look at the Evidence Linking Diet to Skin Conditions
MDedge Rheumatology
Corticosteroid Injections Don’t Move Blood Sugar for Most
MDedge Rheumatology
A Paradox? Higher Male Fertility Seen With Inflammatory Arthritis
MDedge Rheumatology
Commentary: PsA in Women, February 2024
MDedge Rheumatology
Review Finds No Short-term MACE, VTE risk with JAK Inhibitors For Dermatoses
MDedge Rheumatology
Comorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory Diseases
MDedge Rheumatology
Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis
MDedge Rheumatology
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Rheumatology